Search tips
Search criteria 


Logo of jargspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
J Assist Reprod Genet. 2003 February; 20(2): 73–81.
PMCID: PMC3455795

TNF-α in Pregnancy Loss and Embryo Maldevelopment: A Mediator of Detrimental Stimuli or a Protector of the Fetoplacental Unit?


Purpose: Tumor necrosis factor alpha (TNF-α), a multifunctional cytokine, has been identified in the ovary, oviduct, uterus, and placenta, and is expressed in embryonic tissues. For many years TNF-α was mainly considered to be a cytokine involved in triggering immunological pregnancy loss and as a mediator of various embryopathic stresses. However, data collected during the last decade has characterized TNF-α not only as a powerful activator of apoptotic, but also antiapoptotic signaling cascades, as well as revealed its regulatory role in cell proliferation. This review summarizes and conceptualizes the studies addressing TNF-α-activated intracellular signaling and the possible functional role of TNF-α in embryonic development.

Methods: Studies addressing the role of TNF-α in intercellular signaling, in vivo studies addressing the functional role TNF-α in spontaneous and induced pregnancy loss, and studies addressing the role of TNF-α in fetal malformations were reviewed. Comparative studies in TNF-α knockout and TNF-α positive mice were performed to evaluate embryonic death, structural anomalies in fetuses, the degree of apoptosis and cell proliferation, and the activity of molecules such as caspases 3 and 8, the NF-κB, (RelA), IκBα in some target embryonic organs shortly after exposure to embryopathic stresses.

Results: It is proposed that the possible essential function of TNF-α may be to prevent the birth of offspring with structural anomalies.

Conclusions: TNF-α will boost death signaling to kill the embryo if initial events (damages) triggered by detrimental stimuli may culminate in structural anomalies, and stimulate protective mechanisms if the repair of these damages may prevent maldevelopment.

Keywords: Apoptosis, embryo, pregnancy loss, teratogenesis, TNF-α

Full Text

The Full Text of this article is available as a PDF (84K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Terranova PF, Hunter VJ, Roby KF, Hunt JS. Tumor necrosis factor-α in the female reproductive tract. Proc Soc Exp Biol Med. 1995;209:325–342. [PubMed]
2. Kohchi C, Noguchi K, Tanabe Y, Mizuno DI, Soma GI. Constitutive expression of TNF-α and-β genes in mouse embryo: Roles of cytokines as regulator and effector on development. Int J Biochem. 1994;26:111–119. [PubMed]
3. Chaouat G, Menu E, Wegmann TG. Role of lymphokines of the CSF family and of TNF, gamma interferon and IL-2 in placental growth and fetal survival studied in two murine models of spontaneous resorptions. In: Chaouat G, Mowbray JF, editors. Cellular and Molecular Biology of the Maternal-Fetal Relationship. Paris: INSERM/John Libbey Eurotext; 1991. pp. 91–104.
4. Gendron RL, Nestel FP, Lapp WS, Baines MG. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-alpha. J Reprod Fert. 1990;90:395–402. [PubMed]
5. Tangri S, Raghupathy R. Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod. 1993;49:850–856. [PubMed]
6. Romero R, Manogue KH, Mitchell MD, Wu YK, Oyarzun E, Hobbins JC, Cerami A. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol. 1989;161:336–341. [PubMed]
7. Clark DA, Arck PC, Chaouat G. Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol. 1999;41:5–22. [PubMed]
8. Raghupathy R. Pregnancy: Success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 2001;13:219–227. [PubMed]
9. Gorivodsky M, Zemliak I, Orenstein H, Savion S, Fein A, Torchinsky A, Toder V. Tumor necrosis factor alpha mRNA and protein expression in the uteroplacental unit of mice with pregnancy loss. J Immunol. 1998;160:4280–4288. [PubMed]
10. Arck PC, Meroli FS, Manuel J, Chaouat G, Clark DA. Stress-triggered abortion: Inhibition of protective suppression and promotion of tumor necrosis factor-α (TNF-α) release as a mechanism triggering resorptions in mice. Am J Reprod Immunol. 1995;33:74–80. [PubMed]
11. Torchinsky A, Toder V, Carp H, Orenstein H, Fein A. In vivo evidence for the existence of a threshold for hyperglycemia-induced major fetal malformations: Relevance to the etiology of diabetic teratogenesis. Early Pregnancy. 1997;3:27–33. [PubMed]
12. Fein A, Kostina E, Savion S, Orenstein H, Shepshelovich J, Ornoy A, Torchinsky A, Toder V. Expression of tumor necrosis factor-α in the uteroplacental unit of diabetic mice: Effect of maternal immunopotentiation. Am J Reprod Immunol. 2001;46:161–168. [PubMed]
13. Pampfer S. Apoptosis in rodent peri-implantation embryos: Differential susceptibility of inner cell mass and trophectoderm cell lineages: A review. Placenta. 2000;21(SupplA):S3–10. [PubMed]
14. Pampfer S. Dysregulation of the cytokine network in the uterus of the diabetic rat. Am J Reprod Immunol. 2001;45:375–81. [PubMed]
15. Ivnitsky I, Torchinsky A, Gorivodsky M, Zemliak I, Orenstein H, Savion S, Shepshelovich J, Carp H, Fein A, Toder V. TNF-alpha expression in embryos exposed to a teratogen. Am J Reprod Immunol. 1998;40:431–440. [PubMed]
16. Beyaert R, Fiers W. Tumor necrosis factor and lymphotoxin. Cytokines. 1998;24:335–359.
17. Clark DA, Chaouat G, Gorczynsky RM. Thinking outside the box: Mechanisms of environmental selective pressures on the outcome of the materno-fetal relationship. Am J Reprod Immunol. 2002;47:275–282. [PubMed]
18. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol. 1991;138:447–453. [PubMed]
19. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 1997;88:347–354. doi: 10.1016/S0092-8674(00)81873-5. [PubMed] [Cross Ref]
20. Vaux DL, Korsmeyer SJ. Cell death in development. Cell. 1999;96:245–254. [PubMed]
21. Savion S, Lepsky E, Orenstein H, Carp H, Shepshelovich J, Torchinsky A, Fein A, Toder V. Apoptosis in the uterus of mice with pregnancy loss. Am J Reprod Immunol. 2002;47:118–127. [PubMed]
22. Knudsen TV. Cell death. In: Kavlock RJ, Daston GP, editors. Drug Toxicity in Embryonic Development I. Berlin: Springer-Verlag; 1997. pp. 211–244.
23. Mirkes PE. 2001 Warkany lecture: To die or not to die, the role of apoptosis in normal and abnormal mammalian development. Teratology. 2002;65:228–239. [PubMed]
24. Green DR. Apoptotic pathways: The roads to ruin. Cell. 1998;94:695–698. doi: 10.1016/S0092-8674(00)81728-6. [PubMed] [Cross Ref]
25. Pomerantz JL, Baltimore D. Signal transduction. A cellular rescue team. Nature. 2000;406:26–29. [PubMed]
26. Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: Structure-function relationship(s) Microsc Res Tech. 2000;50:184–195. [PubMed]
27. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11:372–377. [PubMed]
28. Menkes B, Sandor S, Ilies A. Cell death in teratogenesis. In: Woollam DH, editor. Advances in Teratology. New York: Academic Press; 1970. pp. 169–215.
29. Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B, Vayssiere JL. TNF-alpha activates at least two apoptotic signaling cascades. Oncogene. 1998;17:1639–1651. [PubMed]
30. Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 1998;17:3261–3270. [PubMed]
31. Chang HY, Yang X. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev. 2000;64:821–846. [PMC free article] [PubMed]
32. Adrain C, Martin SJ. The mitochondrial apoptosome: A killer unleashed by the cytochrome seas. Trends Biochem Sci. 2001;26:390–397. [PubMed]
33. Tsujimoto Y, Shimizu S. Bcl-2 family: Life-or-death switch. FEBS Lett. 2000;466:6–10. [PubMed]
34. Gupta S. Molecular steps of tumor necrosis factor receptor-mediated apoptosis. Current Mol Med. 2001;1:317–324. [PubMed]
35. Cai Z, Capoulade C, Moyret-Lalle C, Amor-Gueret M, Feunteun J, Larsen AK, Paillerets B., Chouaib S. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene. 1997;15:2817–2826. [PubMed]
36. Rokhlin OW, Gudkov AV, Kwek S, Glover RA, Gewies AS, Cohen MB. p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene. 2000;19:1959–1968. [PubMed]
37. Vousden KH. p53: Death star. Cell. 2000;103:692–694. [PubMed]
38. Venters HD, Dantzer R, Kelley KW. A new concept in neurodegeneration: TNFα is a silencer of survival signals. Trends Neurosci. 2000;23:175–180. [PubMed]
39. Rutanen E-M. Insulin-like growth factors in obstetrics. Curr Opin Obstet Gynecol. 2000;12:163–168. [PubMed]
40. van Kleffens M, Groffen C, Lindenbergh-Kortleve DJ, van Neck JW, González-Parra S, Dits N, Zwarthoff EC, Drop SLS. The IGF system during fetal-placental development of the mouse. Mol Cell Endocrin. 1998;140:129–135. [PubMed]
41. Coulam CB. Understanding the immunology of pregnancy and applying it to treatment of recurrent pregnancy loss. Early Pregnancy. 2000;IV:019–029. [PubMed]
42. Torchinsky A, Ivnitsky I, Savion S, Shepshelovich J, Gorivodsky M, Fein A, Carp H, Schwartz D, Frankel J, Rotter V, Toder V. Cellular events and the pattern of p53 protein expression following cyclophosphamide-initiated cell death in various organs of developing embryo. Teratog Carcinog Mutagen. 1999;19:353–367. [PubMed]
43. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NF-κB transcription factors: Structural views. Oncogene. 1999;18:6845–6852. [PubMed]
44. Karin M. Minireview. The beginning of the end: IkB kinase (IKK) and NF-κB activation. J Biol Chem. 1999;274:27339–27342. [PubMed]
45. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene. 1999;18:6853–6866. [PubMed]
46. Karin M, Lin A. NF-κB at the crossroad of life and death. Nut Immunol. 2002;3:221–227. [PubMed]
47. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995;376:167–170. doi: 10.1038/376167a0. [PubMed] [Cross Ref]
48. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Jonson R, Karin M. The IKKβ subunit of IκB kinase (IKK) is essential for Nuclear Factor κB activation and prevention of apoptosis. J Exp Med. 1999;189:1839–1845. [PMC free article] [PubMed]
49. Li Q, Van Antwerp D, Mercuric F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 1999;284:321–325. [PubMed]
50. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA. 1999;96:2994–2999. [PubMed]
51. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity. 1999;10:421–429. [PubMed]
52. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol. 2000;56:997–1007. [PubMed]
53. Torchinsky A, Lishanski L, Wolstein O, Shepshelovich J, Orenstein H, Savion S, Zaslavsky Z, Carp H, Brill A, Dikstein R, Toder V, Fein A. NF-kappaB DNA-binding activity in embryos responding to a teratogen, cyclophosphamide. BMC Dev Biol. 2002;2(1):2. [PMC free article] [PubMed]
54. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999;18:6910–6924. [PubMed]
55. Deveraux QL, Reed JC. IAP family proteins-suppressor of apoptosis. Genes Dev. 1999;13:239–252. [PubMed]
56. Goyal L. Cell death inhibition: Keeping caspases in check. Cell. 2001;104:805–808. [PubMed]
57. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer J-L, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 1997;388:190–195. [PubMed]
58. Mirkes PE, Little SA. Teratogen-induced cell death in postimplantation mouse embryos: differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ. 1998;5:592–600. [PubMed]
59. Mirkes PE, Little SA. Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol Appl Pharmacol. 2000;162:197–206. [PubMed]
60. Aggarwal BB. Apoptosis and nuclear factor-kappaB: A tale of association and dissociation. Biochem Pharmacol. 2000;6:1033–1039. [PubMed]
61. Sharova L, Sura P, Smith BJ, Gogal RM, Jr, Sharov AA, Ward DL, Holladay SD. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology. 2000;62:420–428. [PubMed]
62. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab. 2001;12:78–82. [PubMed]
63. Wilson JG. Current status of teratology: general principles and mechanisms derived from animal studies. In: Wilson JG, Fraser FC, editors. Handbook of Teratology: General Principles and Etiology. New York: Plenum Press; 1977. pp. 47–74.
64. Campbell KJ, Chapman NR, Perkins ND. UV stimulation induces nuclear factor kappaB (NF-kappaB) DNA-binding activity but not transcriptional activation. Biochem Soc Trans. 2001;29(Pt6):688–691. [PubMed]
65. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature. 2000;404:892–897. [PubMed]
66. Wubah JA, Ibrahim MM, Gao X, Nguyen D, Pisano MM, Knudsen TB. Teratogen-induced eye defects mediated by 53-dependent apoptosis. Curr Bio. 1996;6:60–69. [PubMed]
67. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein I, Wells PG. A teratologic suppresser role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet. 1995;10:181–187. [PubMed]
68. Moallem SA, Hales BF. The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxicyclophosphamide-induced limb malformations. Development. 1998;125:3225–3234. [PubMed]
69. Norimura T, Nomoto S, Katsuki M, Gondo Y, Kondo S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat Med. 1996;2:577–580. [PubMed]
70. Wang B. Involvement of p53-dependent apoptosis in radiation teratogenesis and in the radioadaptive response in the late organogenesis of mice. J Radiat Res (Tokyo) 2001;42:1–10. [PubMed]
71. Choi J, Donehower LA. p53 in embryonic development: Maintaining a fine balance. Cell Mol Life Sci. 1999;55:38–47. [PubMed]
72. Snow MHL, Tam PPL. Is compensatory growth a complicating factor in mouse teratology. Nature. 1979;279:555–557. [PubMed]
73. Chen F, Castranova V, Shi X. New insights into the role of nuclear factor-kappa B in cell growth regulation. Am J Pathol. 2001;159:387–397. [PubMed]
74. Tibbles LA, Woodgett R. The stress-activated protein kinase pathways. Cell Mol Life Sci. 1999;55:1230–1254. [PubMed]
75. Wells PG, Kim PM, Laposa RR, Nicol CJ, Parman T, Winn LM. Oxidative damage in chemical teratogenesis. Mutat Res. 1997;396:65–78. [PubMed]
76. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 1996;184:1397–1411. [PMC free article] [PubMed]
77. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA. 1997;94:8093–809. [PubMed]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC